22
Participants
Start Date
June 15, 2023
Primary Completion Date
April 15, 2024
Study Completion Date
May 1, 2024
premix insulin human isophane suspension and insulin human
Sequence (Premix first, then Humulin N + Humulin R): Subjects randomized to this sequence will receive premix insulin, twice per day for 16 weeks. After the first 16 weeks, subjects will cross over to the Humulin N plus Humulin R sequence for a further treatment of 16 weeks
Humulin N plus Humulin R
Sequence (Humulin N + Humulin R first, then Premix): Subjects randomized to this sequence will receive basal bolus insulin scheme with Humulin N (twice daily) and Humulin R (before meals) for 16 weeks. After the first 16 weeks, subjects will cross over to the Premix sequence for a further treatment of 16 weeks
CHU Souro Sanou, Bobo-Dioulasso
CHU de Tengandogo, Ouagadougou
CHU Yalgado Ouedraogo, Ouagadougou
Collaborators (1)
Juvenile Diabetes Research Foundation
OTHER
International Society for Pediatric and Adolescent Diabetes
UNKNOWN
Société de Médecine Interne du Burkina Faso
UNKNOWN
Association pour la Formation, la Recherche et l'Education sur le Diabète, Burkina Faso
UNKNOWN
Université NAZI BONI
OTHER